Page last updated: 2024-08-17

levodopa and Amyotrophic Lateral Sclerosis

levodopa has been researched along with Amyotrophic Lateral Sclerosis in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19904 (26.67)18.7374
1990's1 (6.67)18.2507
2000's8 (53.33)29.6817
2010's1 (6.67)24.3611
2020's1 (6.67)2.80

Authors

AuthorsStudies
Leitinger, G; Maurer, C; Radulović, S; Sunkara, S1
Kim, BJ; Kim, JS; Kim, KK; Kim, SM; Lee, MC; Lim, YM; Park, HK1
Aquilonius, SM; Askmark, H; Gomes-Trolin, C; Nygren, I1
Ferrannini, E; Fraddosio, A; Iliceto, G; Lamberti, S; Maggio, F; Palagano, G; Russo, I; Serlenga, L; Zoccolella, S1
Foster, HD; Hoffer, A1
Fahn, S1
Hideyama, T; Kwak, S; Momose, T; Shimizu, J; Tsuji, S1
Kaneda, D; Oyanagi, K; Shintaku, M1
Adeva-Bartolomé, T; Alonso-Navarro, H; Jiménez-Jiménez, FJ; Ruiz-Ezquerro, JJ1
Johnson, RT; Price, DL1
Matsuoka, H; Mizoguchi, K; Nishimura, Y; Obi, T; Takatsu, M1
Danysz, W1
Gerstenbrand, F; Gründig, E; Weiss, J1
Brody, JA; Kurland, LT; Stanhope, JM1
Akiguchi, I; Itoh, H; Kameyama, M; Nakamura, S; Yamao, S1

Reviews

4 review(s) available for levodopa and Amyotrophic Lateral Sclerosis

ArticleYear
Digging Deeper: Advancements in Visualization of Inhibitory Synapses in Neurodegenerative Disorders.
    International journal of molecular sciences, 2021, Nov-18, Volume: 22, Issue:22

    Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Brain; Humans; Huntington Disease; Levodopa; Memantine; Microscopy, Electron; Multiple Sclerosis; Neuronal Plasticity; Neurons; Neuroprotective Agents; Neurotransmitter Agents; Parkinson Disease; Synapses; Synaptic Transmission; Tetrabenazine

2021
ALS lessons learned from other neurological diseases. Parkinson's disease.
    Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases, 2004, Volume: 5 Suppl 1

    Topics: Amyotrophic Lateral Sclerosis; Antiparkinson Agents; Behavioral Symptoms; Coenzymes; Controlled Clinical Trials as Topic; Disease Progression; Humans; Levodopa; Neuroprotective Agents; Parkinson Disease; Ubiquinone

2004
Neurotoxicity as a mechanism for neurodegenerative disorders: basic and clinical aspects.
    Expert opinion on investigational drugs, 2001, Volume: 10, Issue:5

    Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Humans; Levodopa; Nerve Growth Factor; Neuroprotective Agents; Nicotine; Parkinson Disease

2001
Patterns of Amyotrophic Lateral Sclerosis and Parkinsonism-Dementia on Guam.
    Contemporary neurology series, 1975, Volume: 12

    Topics: Adult; Aged; Amines; Amyotrophic Lateral Sclerosis; Autopsy; Dementia; Demography; Environmental Pollutants; Ethnicity; Female; Gene Frequency; Guam; Humans; Levodopa; Male; Middle Aged; Parkinson Disease, Secondary; Toxins, Biological

1975

Trials

1 trial(s) available for levodopa and Amyotrophic Lateral Sclerosis

ArticleYear
Increased red blood cell polyamines in ALS and Parkinson's disease.
    Experimental neurology, 2002, Volume: 177, Issue:2

    Topics: Amyotrophic Lateral Sclerosis; Biogenic Polyamines; Erythrocytes; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Putrescine; Spermidine; Spermine; Time Factors

2002

Other Studies

10 other study(ies) available for levodopa and Amyotrophic Lateral Sclerosis

ArticleYear
Nigrostriatal dysfunction in patients with amyotrophic lateral sclerosis and parkinsonism.
    Journal of the neurological sciences, 2011, Feb-15, Volume: 301, Issue:1-2

    Topics: Aged; Amyotrophic Lateral Sclerosis; Antiparkinson Agents; Corpus Striatum; Fluorine Radioisotopes; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Parkinsonian Disorders; Positron-Emission Tomography; Presynaptic Terminals; Putamen; Radiopharmaceuticals; Substantia Nigra; Tremor; Tropanes

2011
ALS-plus: 5 cases of concomitant amyotrophic lateral sclerosis and parkinsonism.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2002, Volume: 23 Suppl 2

    Topics: Aged; Amyotrophic Lateral Sclerosis; Antiparkinson Agents; Dementia; Female; Humans; Levodopa; Male; Parkinsonian Disorders

2002
The two faces of L-DOPA: benefits and adverse side effects in the treatment of Encephalitis lethargica, Parkinson's disease, multiple sclerosis and amyotrophic lateral sclerosis.
    Medical hypotheses, 2004, Volume: 62, Issue:2

    Topics: Amyotrophic Lateral Sclerosis; Antioxidants; Antiparkinson Agents; Dopamine Agents; Dyskinesia, Drug-Induced; Gastrointestinal Diseases; Hallucinations; Humans; Levodopa; Multiple Sclerosis; Oxidative Stress; Parkinson Disease; Parkinson Disease, Postencephalitic; Psychoses, Substance-Induced; Sleep Initiation and Maintenance Disorders; Vitamin B Complex

2004
A positron emission tomography study on the role of nigral lesions in parkinsonism in patients with amyotrophic lateral sclerosis.
    Archives of neurology, 2006, Volume: 63, Issue:12

    Topics: Aged; Amyotrophic Lateral Sclerosis; Cerebrovascular Circulation; Female; Humans; Levodopa; Male; Middle Aged; Motor Neuron Disease; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Spiperone; Substantia Nigra; Tomography, Emission-Computed, Single-Photon

2006
Amyotrophic lateral sclerosis with dementia showing clinical parkinsonism and severe degeneration of the substantia nigra: report of an autopsy case.
    Neuropathology : official journal of the Japanese Society of Neuropathology, 2007, Volume: 27, Issue:3

    Topics: Aged; Amyotrophic Lateral Sclerosis; Autopsy; Dementia; Diagnosis, Differential; Dopamine Agents; Fatal Outcome; Humans; Levodopa; Magnetic Resonance Imaging; Male; Parkinson Disease; Parkinsonian Disorders; Substantia Nigra

2007
[Association between amytrophic lateral sclerosis and Parkinson's disease].
    Medicina clinica, 2007, Oct-06, Volume: 129, Issue:12

    Topics: Aged; Amyotrophic Lateral Sclerosis; Antiparkinson Agents; Cabergoline; Carbidopa; Dopamine Agents; Dopamine Agonists; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Neuroprotective Agents; Parkinson Disease; Riluzole; Time Factors; Tomography, X-Ray Computed

2007
Chronic neurological diseases: their societal burdens and potential solutions.
    Journal of chronic diseases, 1980, Volume: 33, Issue:3

    Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Ataxia; Axons; Brain Diseases; Cerebral Cortex; Chronic Disease; Dopamine; Humans; Huntington Disease; Immunoglobulin G; Levodopa; Motor Neurons; Multiple Sclerosis; Parkinson Disease

1980
Muscle cramp as the result of impaired GABA function--an electrophysiological and pharmacological observation.
    Muscle & nerve, 1993, Volume: 16, Issue:11

    Topics: Amyotrophic Lateral Sclerosis; Baclofen; Clomipramine; Diazepam; Electric Stimulation; Evoked Potentials; GABA Antagonists; gamma-Aminobutyric Acid; Humans; Levodopa; Lidocaine; Male; Middle Aged; Motor Neurons; Muscle Cramp; Muscular Atrophy, Spinal; Nerve Block; Neural Conduction; Sensory Thresholds; Ulnar Nerve

1993
[The activity of aminotransferases in serum and cerebrospinal fluid in neurological diseases (author's transl)].
    Wiener klinische Wochenschrift, 1975, Dec-12, Volume: 87, Issue:23

    Topics: Alanine Transaminase; Amyotrophic Lateral Sclerosis; Aspartate Aminotransferases; Craniocerebral Trauma; Friedreich Ataxia; Guanidines; Hepatolenticular Degeneration; Humans; Huntington Disease; Levodopa; Nervous System Diseases; Parkinson Disease; Penicillins; Phenylketonurias; Transaminases

1975
[Levodopa therapy in a patient with ALS-dementia complex].
    Rinsho shinkeigaku = Clinical neurology, 1987, Volume: 27, Issue:9

    Topics: Amyotrophic Lateral Sclerosis; Dementia; Homovanillic Acid; Humans; Levodopa; Male; Middle Aged

1987